MedTrace Logo

Steroid Diabetes in Patients With Kidney Disease

NCT06161701 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-04-29

No results posted yet for this study

Summary

If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.

Conditions

  • Nephrotic Syndrome

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • The Third Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER

  • The First People's Hospital of Xiaoshan District, Hangzhou City

    collaborator UNKNOWN

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine

    collaborator OTHER

  • Nanxun District People's Hospital of Huzhou City，China

    collaborator UNKNOWN

  • Wenling Traditional Chinese Medicine Hospital

    collaborator UNKNOWN

  • Affiliated Hospital of Jiaxing University

    collaborator OTHER

  • Taizhou Hospital

    collaborator OTHER

  • The First People's Hospital of Chun'an

    collaborator UNKNOWN

  • Zhejiang Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Xiaolan Ye, master · Zhejiang Provincial People's Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2026-12-31
Completion
2027-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06161701 on ClinicalTrials.gov